TABLE 3.
Treatment results shown by subgroup in the placebo therapy group (n = 26)
| SUBGROUP | SCORAD BEFORE (MEAN ± SD) | SCORAD AFTER (MEAN ± SD) | P-VALUE (AFTER VS. BEFORE) |
|---|---|---|---|
| All patients | 50±21 | 48±10 | 0.84 |
| Sex | |||
| Males | 52±21 | 44±13 | 0.7 |
| Females | 50±21 | 48±16 | 0.81 |
| Age | |||
| <17 years | 47±19 | 47±19 | 0.99 |
| ≥17 years | 54±23 | 50±20 | 0.84 |
| Duration | |||
| <7 years | 55±21 | 51±18 | 0.86 |
| ≥7 years | 47±20 | 47±18 | 0.99 |
| Onset | |||
| <1.5 years | 53±19 | 54±19 | 0.98 |
| ≥1.5 years | 48±22 | 45±20 | 0.66 |
| Baseline disease severity | |||
| Mild (SCORAD < 25 points) | 20±4 | 17±5 | 0.74 |
| Moderate (SCORAD 25–50 points) | 38±8 | 21±7 | 0.61 |
| Severe (SCORAD > 50 points) | 69±11 | 64±14 | 0.81 |